Overview
Ting Tang practices practicing medicine in Kuala Lumpur, Malaysia.
Her clinical expertise encompasses RUNX1 Familial Platelet Disorder, Chlamydia, and Multiple Myeloma.
She is actively involved in clinical research, co-authoring 12 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ting F. Tang
Is Ting F. Tang a top-rated expert for RUNX1 Familial Platelet Disorder?
MediFind is an objective health platform that identifies experts based on real-world data. Ting F. Tang is classified as an Experienced expert for RUNX1 Familial Platelet Disorder, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ting F. Tang participate in research or clinical trials?
Yes. Ting F. Tang has published 12 articles and abstracts on conditions like RUNX1 Familial Platelet Disorder. You can view a list of Ting F. Tang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ChlamydiaMs. Tang isExperienced. Learn about Chlamydia.
- Multiple MyelomaMs. Tang isExperienced. Learn about Multiple Myeloma.
- RUNX1 Familial Platelet DisorderMs. Tang isExperienced. Learn about RUNX1 Familial Platelet Disorder.